Join our Co-Founder and CEO, Tim Lu, today for a fireside chat at Chardan’s 8th Annual Genetic Medicines Conference as he shares company highlights. Visit the events page of our website for webcast details and archived recordings: https://lnkd.in/eC93_hEp $SNTI #celltherapy #synbio
Senti Biosciences’ Post
More Relevant Posts
-
DPYD PGx testing is an easy way to ensure you get the right dose of fluorouracil-based chemotherapy. It may not be part of clinical guidelines, but when DPYD testing has such a high level of evidence, it should be.
DPYD genetic variants could cause severe adverse effects and even death. DPYD Pharmacogenomic testing is currently in the guidelines for 5 Fluorouracil , Capecitabine and Tegafur. Ask your oncologist for genetic testing options. https://lnkd.in/grB4zFda
To view or add a comment, sign in
-
DPYD genetic testing is crucial before the administration of 5-FU, capecitabine and tegafur.🙌🤞Stay on a safe side✅
DPYD genetic variants could cause severe adverse effects and even death. DPYD Pharmacogenomic testing is currently in the guidelines for 5 Fluorouracil , Capecitabine and Tegafur. Ask your oncologist for genetic testing options. https://lnkd.in/grB4zFda
To view or add a comment, sign in
-
Did you miss the recent Devyser webinar with Dr. Robert Akkers highlighting the shifting distribution of hemoglobinopathy and the need for expanded thalassemia genetic testing? Now watch the on-demand webinar here: https://bit.ly/3RPitjr #thalassemia #ngs #genetictesting
To view or add a comment, sign in
-
For the most part, the technology used to treat #Duchenne muscular dystrophy has been focused on exon skipping. But as is the case with many boys with the condition, my son Caffrey's mutation is not amenable to this type of treatment. That’s why we need to continue to develop additional therapeutic options for #DMD. Thank you, Rare Disease Advisor, for the opportunity to share Caffrey’s story and how his diagnosis helped me appreciate the sheer unmet medical need there is not only within the Duchenne community, but also broadly across all #rarediseases – and what we are doing at @Alltrna to accelerate #raredisease #drugdevelopment.
Alltrna’s CEO Michelle Werner discusses with Larry Luxner of Rare Disease Advisor her personal and professional mission to accelerate #raredisease #drugdevelopment and how new tRNA genetic medicines could do this: by treating many diseases at once. 🎧 Listen to the interview: https://lnkd.in/gStF48fc #tRNA #RNA #tRNAmedicines #tRNAbiology #rarediseases #StopCodonDisease #geneticmedicines #programmablemedicines
Alltrna's Michelle Werner Interviewed for Rare Disease Advisor
To view or add a comment, sign in
-
Do you want to use ClinVar to better understand genetic testing results? Check out GenomeConnect’s recent webinar “ClinVar - How to Search and How to Track a Variant” ⬇️ https://ow.ly/2XTW50U2BmK
To view or add a comment, sign in
-
Access the newest article from Pharma insights! Learn how RGD peptide-based lipids are revolutionizing mRNA delivery, offering targeted precision and enhanced efficacy in treating genetic disorders. Click here: https://ow.ly/MSIs30sCfSz #CrodaPharma #EmpoweringBiologicsDelivery #PharmaInsights
To view or add a comment, sign in
-
Join our webinar at 12:00 PM on May 2nd to how Allysta Pharmaceuticals is developing a completely new treatment for Duchenne Muscular Dystrophy, a genetic disease that affects men starting in childhood. https://hubs.la/Q02tLKSK0
To view or add a comment, sign in
-
Access the newest article from Pharma insights! Learn how RGD peptide-based lipids are revolutionizing mRNA delivery, offering targeted precision and enhanced efficacy in treating genetic disorders. Click here: https://ow.ly/G93Q30sCgLi #CrodaPharma #EmpoweringBiologicsDelivery #PharmaInsights
To view or add a comment, sign in
-
Join our webinar at 12:00 PM on May 2nd to how Allysta Pharmaceuticals is developing a completely new treatment for Duchenne Muscular Dystrophy, a genetic disease that affects men starting in childhood. https://hubs.la/Q02tLQ270
To view or add a comment, sign in
-
Join our webinar at 12:00 PM on May 2nd to how Allysta Pharmaceuticals is developing a completely new treatment for Duchenne Muscular Dystrophy, a genetic disease that affects men starting in childhood. https://hubs.la/Q02tLQjX0
To view or add a comment, sign in
9,732 followers